To sum up, targeting hypoxic EMT through ncRNAs which interact with master regulators such as HIF1-α should be considered an interesting research direction in unveiling novel therapeutic approaches in the treatment of gliomas. The gene discussed is HIF1A; the disease is central nervous system cancer.